1
2
Westgeest, H.M., Kuppen, M., van den Eertwegh, A.J.M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A.C.M., Coenen, J.L., Aben, K.K.H., Somford, R., de Wit, R., Bergman, A., Lavalaye, J., Uyl-de Groot, C.A., Gerritsen, W.R.
Veröffentlicht in: Annals of Oncology ; volume 29, page viii283-viii284 ; ISSN 0923-7534;
2018
Veröffentlicht in: Annals of Oncology ; volume 29, page viii283-viii284 ; ISSN 0923-7534;
2018
3
Westgeest, H. M., Kuppen, M., van den Eertwegh, A. J.M., Van Moorselaar, J., Mehra, N., van Oort, I., van den Bergh, A. C.M., Coenen, J. L., Aben, K. K.H., Somford, R., de Wit, R., Bergman, A., Lavalaye, J., Uyl-de Groot, C. A., Gerritsen, W. R.
Veröffentlicht in: Westgeest , H M , Kuppen , M , van den Eertwegh , A J M , Van Moorselaar , J , Mehra , N , van Oort , I , van den Bergh , A C M , Coenen , J L , Aben , K K H , Somford , R , de Wit , R , Bergman , A , Lavalaye , J , Uyl-de Groot , C A & Gerritsen , W R 2018 , ' Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI : An observational study in the Netherlands ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii283-viii284 . https://doi.org/10.1093/annonc/mdy284.026;
2018
Veröffentlicht in: Westgeest , H M , Kuppen , M , van den Eertwegh , A J M , Van Moorselaar , J , Mehra , N , van Oort , I , van den Bergh , A C M , Coenen , J L , Aben , K K H , Somford , R , de Wit , R , Bergman , A , Lavalaye , J , Uyl-de Groot , C A & Gerritsen , W R 2018 , ' Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI : An observational study in the Netherlands ' , Annals of oncology : official journal of the European Society for Medical Oncology , vol. 29 , pp. viii283-viii284 . https://doi.org/10.1093/annonc/mdy284.026;
2018